Rolipram
Alternative Names: ME 3167; ZK 62711Latest Information Update: 24 Oct 2021
At a glance
- Originator Bayer Schering Pharma
- Developer Bayer Schering Pharma; Meiji Seika Kaisha
- Class Antidepressants; Hepatoprotectants; Small molecules
- Mechanism of Action Apoptosis stimulants; Type 4 cyclic nucleotide phosphodiesterase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Asthma; Glioma; HIV-1 infections; Major depressive disorder; Rheumatoid arthritis